Whitehawk Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -4.79%
- Market cap
- $181.75M
- 59.01M shares
- Filings
- 676
Q3 2026−72.5% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+31.0% FY25 yoy
- $181.75M
- —
- —
- 1.1×
- -40.52%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $7,145,000 | reported | |
| FY 2024 | 2024-12-31 | $25,983,000 | reported | |
| FY 2023 | 2023-12-31 | $24,354,000 | reported | |
| FY 2022 | 2022-12-31 | $15,216,000 | reported | |
| FY 2021 | 2021-12-31 | $14,000,000 revised | reported | |
| FY 2020 | 2020-12-31 | $14,000,000 revised | reported | |
| FY 2019 | 2019-12-31 | $0 | reported | |
| FY 2018 | 2018-12-31 | $20,157,430 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2022 | $0.00 | — | $0.00 | — | 24.44M sh | +16.8% | — |
| FY2021 | $4.41M | — | $4.41M | — | 20.93M sh | −55.8% | — |
Segments
LineFY2025ShareChange
Reportable Segment$7.15M100%−72.5%
Reportable Segment———
Total$7.15M
Pharmaceutical preparations
Whitehawk Therapeutics, Inc. is the 182nd largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
COYACoya Therapeutics, Inc.$7.9M123.6%267.1%$75.8MACRSAclaris Therapeutics, Inc.$7.8M58.2%829.6%$635.2MBOLTBolt Biotherapeutics, Inc.$7.7M0.1%433.7%$17.0MADAGAdagene Inc.$7.7M7,332.8%229.6%—XENEXenon Pharmaceuticals Inc.$7.5M—4,612.1%$4.0BOVIDOvid Therapeutics Inc.$7.3M1,181.3%240.1%$479.4M
WHWKWhitehawk Therapeutics, Inc. (this company)$7.1M72.5%288.3%$181.7M
IMNMImmunome Inc.$6.9M23.2%3,060.0%$2.2BKYNBKyntra Bio, Inc.$6.4M78.3%2,848.6%$19.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR